Hinge Bio Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $30.6M

  • Investors
  • 9

Hinge Bio General Information

Description

Operator of a biotech company intended to work for the development of a new class of flexible, extendible, and cooperatively binding therapeutics and diagnostics. The company focuses on facilitating therapeutics capable of simultaneously binding either a disease target with multiple hands and targeting different oncology, metabolic disease, and neurodegenerative disorders, enabling medical providers to diagnose diseases at an early stage and provide proper treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 900 Island Drive
  • Suite 102
  • Redwood City, CA 94065
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 900 Island Drive
  • Suite 102
  • Redwood City, CA 94065
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hinge Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 15-Jan-2025 $30.6M Completed Generating Revenue
6. Later Stage VC 01-Feb-2021 Completed Startup
5. Later Stage VC (Series A) 27-Feb-2020 Completed Startup
4. Grant 01-Jan-2018 Completed Startup
3. Grant 31-Dec-2017 Completed Startup
2. Accelerator/Incubator 18-Apr-2017 Completed Startup
1. Grant 01-Jan-2017 $225K Completed Startup
To view Hinge Bio’s complete valuation and funding history, request access »

Hinge Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A'
Series A
To view Hinge Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hinge Bio Patents

Hinge Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026107318-A1 A cd19/cd20 bispecific antibody with dual fc domains Pending 15-Nov-2024
WO-2026107307-A1 Tetrahedral constructs binding folate and cd3 Pending 15-Nov-2024

Hinge Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hinge Bio Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
InVivium Capital Venture Capital Minority
Lightswitch Capital PE/Buyout Minority
Point72 Asset Management Hedge Fund Minority
Ridgeback Capital Venture Capital Minority
Thornapple River Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Hinge Bio FAQs

  • When was Hinge Bio founded?

    Hinge Bio was founded in 2015.

  • Where is Hinge Bio headquartered?

    Hinge Bio is headquartered in Redwood City, CA.

  • What is the size of Hinge Bio?

    Hinge Bio has 20 total employees.

  • What industry is Hinge Bio in?

    Hinge Bio’s primary industry is Drug Discovery.

  • Is Hinge Bio a private or public company?

    Hinge Bio is a Private company.

  • What is the current valuation of Hinge Bio?

    The current valuation of Hinge Bio is .

  • What is Hinge Bio’s current revenue?

    The current revenue for Hinge Bio is .

  • How much funding has Hinge Bio raised over time?

    Hinge Bio has raised $66.8M.

  • Who are Hinge Bio’s investors?

    InVivium Capital, Lightswitch Capital, Point72 Asset Management, Ridgeback Capital, and Thornapple River Capital are 5 of 9 investors who have invested in Hinge Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process